Stay updated with breaking news from Develop Drugs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BridgeBio Pharma (BBIO) said the first patient with non-small cell lung cancer ((NSCLC)) was dosed in a phase 1/2 trial of BBP-398 with Bristol Myers Squibb's (BMY) Opdivo (nivolumab)...
Xortx Therapeutics (XRTXF) (XRTX) reported data from a bridging pharmacokinetics trial of its proprietary formulation of oral oxypurinol, Xorlo being explored for kidney disease.The...
Relief Therapeutics (RLFTF)(RLFTD) reported six-month stability data on a new formulation of potential lung disease therapy RLF-100 (aviptadil).The company said the data showed high...
Galapagos has a new CEO since April 2022. The new strategy is taking shape with some research programs scrapped and small assets acquired. Read more here.
Intercept Pharmaceuticals (ICPT) stock fell ~18% on Sept